CoreAge Rx vs NuuVim
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NuuVim head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 62 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make NuuVim a bad call — it's best for people comparing injection and sublingual options who can budget for three-month billing and the published renewal rate. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | NuuVim |
|---|---|---|
| Brief Score | 94/100 (A) | 62/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $237 first 3 months New GLP-1 users; standard $399 per three-month plan. Injection or sublingual liquid; selected prescription quote unknown. Full price detailsCompounded semaglutide injection or sublingual liquid offered; complete selected-plan quote unknown; $237 first 3 months for new GLP-1 users, then $399 per 3-month standard plan; advertised monthly equivalents $79 then $133 |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $399 first 3 months New GLP-1 users; standard $599 per three-month plan. Injection or sublingual liquid; selected prescription quote unknown. Full price detailsCompounded tirzepatide injection or sublingual liquid offered; complete selected-plan quote unknown; $399 first 3 months for new GLP-1 users, then $599 per 3-month standard plan; advertised monthly equivalents $133 then $199.67 |
| Coverage | US only; restrictions by state, confirmed at intake | Terms advertise all 50 states plus DC, subject to clinician licensing and medication, formulation and pharmacy restrictions. |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
NuuVim: NuuVim offers injectable and oral GLP-1 plans, but its lowest prices require a three-month payment and increase after the introductory period.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.